Location History:
- La Habana, CU (2015)
- Havana, CU (2019)
Company Filing History:
Years Active: 2015-2019
Title: Innovations of Carlos Antonio Duarte Cano
Introduction
Carlos Antonio Duarte Cano is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the fight against HIV. With two patents to his name, his work focuses on innovative methods to inhibit the replication of the human immunodeficiency virus.
Latest Patents
Duarte Cano's latest patents include a method for inhibiting HIV replication in mammal and human cells. This invention describes a technique to inhibit the replication of HIV by negatively modulating or altering the cytoskeleton, specifically targeting the proteins vimentin and keratin-10. By intervening in the structure of these proteins, the replication of the virus is inhibited in human cells. The invention also relates to the use of agents, such as peptides, interfering RNA, and lipidic compounds, which produce a negative modulation of the cytoskeleton to prevent or treat HIV infection. The methods provided by this invention aim to alter the cytoskeletal structure of cells, thereby disturbing and potentially completely inhibiting HIV infection.
Career Highlights
Throughout his career, Carlos Antonio Duarte Cano has worked with prominent institutions, including the Centro de Ingeniería Genética y Biotecnología. His research and innovations have contributed to advancements in genetic engineering and biotechnology, particularly in the context of viral infections.
Collaborations
Duarte Cano has collaborated with notable colleagues such as Celia Berta Fernandez Ortega and Dionne Casillas Casanova. These collaborations have further enriched his research and development efforts in the field of biotechnology.
Conclusion
Carlos Antonio Duarte Cano's innovative work in inhibiting HIV replication showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against viral infections, and his patents reflect a commitment to improving health outcomes.